Clearside Biomedical, Inc. (NASDAQ:CLSD) Given Average Recommendation of "Buy" by Analysts
Shares of Clearside Biomedical, Inc. (NASDAQ:CLSD – Get Free Report) have been given an average recommendation of “Buy” by the four brokerages that are presently covering the stock, MarketBeat reports. Four investment analysts have rated the stock with a buy recommendation. The average 1-year target price among analysts that have covered the stock in the […]